SCHEMBL31412430

SCHEMBL31412430

Cn1nc(-c2ccon2)cc1C(N)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.37
PHGDH O43175 9/20 0.37
KDM4E B2RXH2 1/20 0.34
GRN P28799 1/20 0.34
SORT1 Q99523 1/20 0.34
CDK8 P49336 2/20 0.34
CCNC P24863 1/20 0.34
SYK P43405 4/20 0.33
JAK2 O60674 3/20 0.33
FLT3 P36888 3/20 0.33
LYN P07948 1/20 0.33
PTPN1 P18031 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
AURKA O14965 1/20 0.31
CSF1R P07333 1/20 0.31
RET P07949 1/20 0.31
LTK P29376 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26639207 0.86 KDM4E (0.49) CHRM1PHGDHKDM4EGRNSORT1
SCHEMBL21233114 0.74 CHRM1 (0.39) CHRM1KDM4ERETNPC1RAB9A
SCHEMBL2678185 0.73 PHGDH (0.60) PHGDHPTPN1
SCHEMBL15048551 0.73 KLK3 (0.48) PHGDHKDM4ESYKJAK2FLT3
SCHEMBL31412366 0.72 BRD4 (0.36) PHGDHKDM4EGRNSORT1CDK8
SCHEMBL22951410 0.71 CHRM1 (0.37) CHRM1KDM4ERETNPC1RAB9A
SCHEMBL3103714 0.71 MAPT (0.51) PHGDHKDM4EPTPN1NPC1RAB9A
SCHEMBL5333233 0.71 HDAC3 (0.55) PHGDHKDM4EPTPN1
SCHEMBL15048611 0.71 PDE10A (0.40) PHGDHSYKJAK2FLT3
SCHEMBL15048497 0.71 PDK1 (0.48) PHGDHKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066323-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2025-02-27 US disclosed
WO-2025038786-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2025-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066323-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS METAP1, SARS1, RTF1 CHRM1 3003/4885PHGDH 2280/4885KDM4E 3879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.